Cargando…
Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy
BACKGROUND: Transgender women (TW) are at increased risk for both human immunodeficiency virus (HIV) and cardiovascular disease (CVD). Antiretroviral therapy-treated HIV has been associated with a two-fold increased risk of CVD, potentially due to dysregulated Toll-like receptor (TLR)-induced immune...
Autores principales: | Kettelhut, Aaren, Bowman, Emily, Gabriel, Janelle, Hand, Brittany, Liyanage, Namal P. M., Kulkarni, Manjusha, Avila-Soto, Frances, Lake, Jordan E., Funderburg, Nicholas T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205606/ https://www.ncbi.nlm.nih.gov/pubmed/35720418 http://dx.doi.org/10.3389/fimmu.2022.879600 |
Ejemplares similares
-
A Randomized Clinical Trial of Transgender Women Switching to B/F/TAF: The (mo)BETTA Trial
por: Lake, Jordan E, et al.
Publicado: (2023) -
In Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles
por: Bowman, Emily R., et al.
Publicado: (2020) -
Impact of Heroin and HIV on Gut Integrity and Immune Activation
por: Hileman, Corrilynn O., et al.
Publicado: (2022) -
Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons
por: Bowman, Emily R., et al.
Publicado: (2019) -
937. Virally Suppressed PLH Switching From Abacavir to Tenofovir Alafenamide Did Not Have Changes in Immune Activation or Inflammation
por: Funderburg, Nicholas, et al.
Publicado: (2018)